Back to search

National and Kapodistrian University of Athens

Πρωτεομική ανάλυση για την ανίχνευση βιοδεικτών στις φλεγμονώδεις νόσους του εντέρου

Abstract

dc:description

ObjectiveAim of this thesis was to reveale biomarkers to understand the pathogenesis, early diagnosis and response to IFX. For this purpose, differential expression of proteins in serum of children and adults with Crohn’s disease (CD) was measured, using proteomic techniques. The adult group included subjects treated with IFX and divided into three groups according to clinical and serological response to therapy. Materials & MethodsSerum samples from adults and children with active CD and adults who either had achieved clinical and serological remission (Rm), or response (Rs) and/or were primary non responders (PNRs) to IFX were subjected to two-dimensional Gel Electrophoresis. Following relative quantitation of protein spots exhibiting differential expression among the groups by densitometry, and further characterization by MALDI-TOF-MS. Results were further confirmed by Western blot analysis.ResultsClusterin (CLUS) was found to be significantly expressed in adults, whereas the Ceruloplasmin (CERU) and Apolipoprotein B-100 (APOB) were found to be significantly over-expressed in children population indicating that those expressions might be implicated on the onset or progression of CD. In the PNR and Rs groups, apolipoprotein A-I (APOΑ1), apolipoprotein E (APOE), complement C4-B (CO4B), plasminogen (PLMN), serotransferrin (TRFE), beta-2-glycoprotein 1 (APOH), and clusterin (CLUS) were found to be up-regulated, whereas their levels displayed no changes in the Rm group when compared to baseline samples. Additionally, leucine-rich alpha-2-glycoprotein (A2GL), vitamin D-binding protein (VTDB), alpha-1B-glycoprotein (A1BG) and complement C1r subcomponent (C1R) were significantly increased in the serum of the Rm group. ResultsThrough the incorporation of proteomics technologies, novel serum marker-molecules demonstrating high sensitivity and specificity are introduced, hence offering an innovative approach regarding the evaluation of CD patients’ response to IFX therapy and early onset of disease.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vaiopoulou, Anna
  • Βαϊοπούλου, Άννα

Subjects

dc:subject × 11

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/35998

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vaiopoulou, Anna; Βαϊοπούλου, Άννα. Πρωτεομική ανάλυση για την ανίχνευση βιοδεικτών στις φλεγμονώδεις νόσους του εντέρου. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/35998